Surgical valve technologies

Minimally invasive mitral valve replacement redo surgery under ventricular fibrillation in a patient with dextrocardia and situs inversus totalis: a case report

Published on 06/02/2025 | Han Yu 1 et al. | Journal of Cardiothoracic Surgery 2024; 20(1): 81 | 10 minute read

Abstract Background Dextrocardia is a rare cardiac malposition where the heart’s normal orientation is reversed and is most commonly associated

Surgical valve technologies

The Role of Global Longitudinal Strain in Predicting Left Ventricular Reverse Remodeling After Mitral Valve Replacement Surgery in Patients With Primary Mitral Regurgitation

Published on 16/01/2025 | Liem Audi Natalino 1 et al. | Echocardiography 2024; 41(11): 15950 | 19 minute read

Abstract Objectives This study aimed to identify the utility of global longitudinal strain (GLS) as a reliable parameter that can

Surgical valve technologies

Outcomes of tricuspid valve surgery in patients with significant tricuspid regurgitation and low to intermediate risk

Published on 02/01/2025 | Seo-Yeon Gwak et al. | Heart 2024; aop:10.1136/heartjnl-2024-324891 | 18 minute read

Abstract Background In patients with tricuspid regurgitation (TR), delayed surgical intervention is associated with poor outcomes, particularly in advanced stages.

Surgical valve technologies

Whether monitored anesthesia care is the optimal anesthetic strategy for transcatheter aortic valve implantation surgery? a meta-analysis and systematic review

Published on 19/12/2024 | Xie Lili 1 et al. | BMC Anesthesiology 2024; 24(1): 429 | 25 minute read

Abstract Objectives To explore whether monitored anesthesia care is more beneficial to the outcome of transcatheter aortic valve implantation.Methods The

Surgical valve technologies

Right ventricular to pulmonary arterial coupling as a predictor of survival in patients undergoing mitral valve surgery for mitral regurgitation

Published on 05/12/2024 | Omar Chehab et al. | European journal of cardio-thoracic surgery 2024; aop: 10.1093/ejcts/ezae421 | 0 minute read

Surgical valve technologies

Short-term outcome after isolated tricuspid valve surgery: prognostic role of right ventricular strain

Published on 21/11/2024 | Francesco Ancona et al. | European journal of cardio-thoracic surgery 2024; aop: 10.1093/ejcts/ezae405 | 0 minute read

Surgical valve technologies

The value of Age-adjusted Charlson and Elixhauser-Van Walraven comorbidity index in predicting prognosis for patients undergoing heart valve surgery

Published on 07/11/2024 | Lv Xingping et al. | Journal of Cardiothoracic Surgery 2024; 19(1): 613 | 14 minute read

Abstract Objective This study aims to compare the efficacy of the Age-adjusted Charlson Comorbidity Index (ACCI) and the Elixhauser-Van Walraven

Surgical valve technologies

Right thoracotomy with central cannulation for valve surgery: 10 years of experience

Published on 17/10/2024 | Sharma Anil et al. | Journal of Cardiothoracic Surgery 2024; 19(1): 596 | 17 minute read

Abstract Background The aim of this study is to report the early outcomes of valvular heart surgeries performed via the

Surgical valve technologies

Surgery Versus Thrombolytic Therapy for the Management of Left‐Sided Prosthetic Valve Thrombosis Without Hemodynamic Compromise: A Systematic Review and Meta‐Analysis

Published on 03/10/2024 | RomainChopardMD et al. | Journal of the American Heart Association 2024; 13(19): 035143 | 23 minute read

Abstract Background The optimal strategy in prosthetic heart valve thrombosis (PVT) remains controversial, with no randomized trials and conflicting observational

Surgical valve technologies

Permanent pacemaker implantation after combined mitral- and tricuspid valve surgery—a nationwide multicentre study

Published on 19/09/2024 | Jules R Olsthoorn et al. | European journal of cardio-thoracic surgery 2024; aop: 10.1093/ejcts/ezae328 | 0 minute read

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.